As of Apr 24
| +0.16 / +3.50%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 6.84, with a high estimate of 6.84 and a low estimate of 6.84. The median estimate represents a +44.61% increase from the last price of 4.73.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.